Freestone Grove Partners LP Procept Bio Robotics Corp Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 2,575 shares of PRCT stock, worth $168,379. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,575Holding current value
$168,379% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$336 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$228 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$115 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$97.5 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$78.9 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.92B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...